Samuel Allen Hamood

Insider Reports History

Location
Chicago, IL
Signature
By: /s/ John Blenke, Attorney-in-Fact for Samuel Allen Hamood
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samuel Allen Hamood:

Form 4 holding Director

Finch Therapeutics Group, Inc.

Security class
Stock Option (right to buy)
Shares / value
44,843
Estimated value
Report date
13 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Samuel Allen Hamood

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .